Brain

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive intracranial pressure (ICP) diagnostic and…

9 hours ago

Restart Life Announces Food Technology and Research Studies

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)…

14 hours ago

Restart Life Announces Food Technology and Research Studies

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)…

14 hours ago

Washington Research Foundation announces 2026 cohort of WRF Postdoctoral Fellows

12 early-career researchers will receive three years of support to carry out projects at the Institute for Systems Biology, University…

15 hours ago

Insightec Announces Spin-Out of Lotus Neuro to Advance Focused Ultrasound Brain Therapies

Lotus Neuro builds on Insightec's groundbreaking focused ultrasound platform to accelerate next-generation brain therapies globally, with funding from Nexus NeuroTech…

15 hours ago

Kara Ball Recognized with Bezos Courage & Civility Award by Jeff Bezos and Lauren Sánchez Bezos

$5 million grant to Understood.org honors Ball's leadership in helping students with learning and thinking differences receive access to STEM…

15 hours ago

Bioptimus Unveils M-Optimus, a World Model for Biology

Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical…

15 hours ago

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of AtlantaResults demonstrated…

18 hours ago

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of AtlantaResults demonstrated…

18 hours ago

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities…

18 hours ago